# Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/progress-of-immune-checkpoint-inhibitors-in-the-treatment-of-advanced/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tong Liu,Guorui Meng,Shihui Ma,Junqi You,Liang Yu,Risheng He,Xudong Zhao,Yunfu Cui |
| Citations | 9 |
| DOI | 10.3389/fimmu.2024.1455716 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1455716/pdf |
| OpenAlex ID | https://openalex.org/W4401471874 |
| PMID | 39185414 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Risheng He](https://scholariq.org/researchers/risheng-he/)

## Paper journal

- [Frontiers in Immunology](https://scholariq.org/journals/frontiers-in-immunology/)

## Paper primary topic

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)

## Paper topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.